Cipla subsidiaries incorporate wholly owned subsidiary in Mexico

Published On 2024-01-24 09:30 GMT   |   Update On 2024-01-24 09:35 GMT
Advertisement

Mumbai: Cipla has announced that Mexicip S.A. de C.V. ("Mexicip") has been incorporated as a wholly owned subsidiary ("WOS") in Mexico jointly by Cipla (EU) Limited, UK and Cipla Holding BV, Netherlands, WOS of the Company.

"We hereby notify that Cipla (EU) Limited, UK and Cipla Holding BV, Netherlands, wholly owned subsidiaries of the Company have jointly incorporated ‘Mexicip S.A. de C.V.’, a wholly owned subsidiary in Mexico w.e.f. 22nd January, 2024," Cipla informed in a BSE filing.

Advertisement

Mexicip is incorporated with an objective of sale and distribution of pharmaceutical drugs in Mexico.

Read also: Cipla, Kemwell Biopharma, Manipal forge cell therapy alliance in US

Cipla Limited is an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India. Khwaja Abdul Hamied founded the Company in 1935 in Mumbai. Cipla has extended its presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. The Company is also deepening its presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Read also: Cipla reports 32 percent increase in net profit to Rs 1056 crore in Q3

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News